Review
Open access
Sep 2026
Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials
Background Overweight status, obesity, and diabetes represent significant socioeconomic burdens that require long-term management. Methods To evaluate the efficacy and safety of dual-agonist CagriSema vs semaglutide monotherapy, cagrilintide monotherapy, and placebo in adults with overweight/obese status and type 2 dia...
Chu-Han Shao, Han-Mo Lin, Jie Yu et al.
· Diabetes, Metabolic Syndrome... · 0 citations